Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome | |
Liu Shuang; Li Chen; Tang Ming-Wei; Xu Wen-Shuai; Chen Ke-Qi; Sui Xin; Tian Xin-Lun; Xu Kai-Feng | |
2019 | |
卷号 | 132期号:19页码:2378-2379 |
ISSN号 | 2542-5641 |
DOI | 10.1097/CM9.0000000000000441 |
URL标识 | 查看原文 |
收录类别 | PUBMED ; CMA系列 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6335458 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Liu Shuang,Li Chen,Tang Ming-Wei,et al. Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome[J],2019,132(19):2378-2379. |
APA | Liu Shuang.,Li Chen.,Tang Ming-Wei.,Xu Wen-Shuai.,Chen Ke-Qi.,...&Xu Kai-Feng.(2019).Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome.,132(19),2378-2379. |
MLA | Liu Shuang,et al."Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome".132.19(2019):2378-2379. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论